Cryptopharmaceuticals: Increasing the Safety of Medication by a Blockchain of Pharmaceutical Products.


Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
09 2019
Historique:
received: 21 12 2018
accepted: 18 04 2019
pubmed: 6 5 2019
medline: 22 8 2020
entrez: 6 5 2019
Statut: ppublish

Résumé

The future health-care system will contain an ever expanding number of digital elements. The data stored both at a centralized health-care level and at a local, patient level (e.g., on a smartphone) will be core elements when deciding treatment strategies in a health-care scenario with Internet of things-based elements. The current way of manufacturing pharmaceutical products and related existing logistic solutions is not ready for such a revolution. One of the key challenges is cybersecurity and related robust public key infrastructure solution. This work introduces one element of a potential solution at a prototype level: the concept of cryptopharmaceuticals where pharmaceutical products are connected in a patient-specific blockchain of individual dosage units. This technology is based on the concept where each produced dosage unit has a unique information-rich pattern. A proof-of-concept smartphone application was applied to demonstrate the visualization of this blockchain at different levels. This includes the manufacturing of the individualized dosage unit, the patient view for his/her personal blockchain, and integration of these products into a health Internet of things system. This unbreakable blockchain of personal medication history will provide means to avoid counterfeit products and to enable innovative logistic solutions.

Identifiants

pubmed: 31054889
pii: S0022-3549(19)30293-X
doi: 10.1016/j.xphs.2019.04.025
pii:
doi:

Substances chimiques

Counterfeit Drugs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2838-2841

Informations de copyright

Copyright © 2019 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Auteurs

Lasse Nørfeldt (L)

Norfeldt Consulting, Sofielundsvägen 23A, Malmö, Sweden.

Johan Bøtker (J)

Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.

Magnus Edinger (M)

Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.

Natalja Genina (N)

Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.

Jukka Rantanen (J)

Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Electronic address: jukka.rantanen@sund.ku.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH